Hanife Sevgi Varlı

Ms. Hanife Sevgi Varlı

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2019 in Journal of Nanoparticle Research
Verified
Journal Article
Closed access
PDF file
HVHanife Sevgi Varlı
Hanife Sevgi Varlı
FAFunda Alkan
Funda Alkan
MDMurat Demirbilek
Murat Demirbilek
NTNelisa TÜRKOĞLU
Nelisa TÜRKOĞLU

Verified
Journal Article
Open access
PDF file
HVHanife Sevgi Varlı
Hanife Sevgi Varlı
MYMERYEM AKKURT YILDIRIM
MERYEM AKKURT YILDIRIM
KKKadriye Kızılbey
Kadriye Kızılbey
NTNelisa TÜRKOĞLU
Nelisa TÜRKOĞLU
This study presents a novel biotechnological approach using octadecylamine-based solid lipid nanoparticles (OCTNPs) for the first-time reprogramming of human CCD1072-SK fibroblast cells into induced pluripotent stem cells (iPSCs). OCTNPs, with an average size of 178.9 nm and a positive zeta potential of 22.8 mV, were synthesized, thoroughly characterized, and utilized as a non-viral vector to efficiently deliver reprogramming factors, achieving a remarkable transfection efficiency of 82.0%. iPSCs were characterized through immunofluorescence, flow cytometry, and RT-qPCR, confirming the expression of key pluripotency markers such as OCT4, SOX2, and KLF4, with alkaline phosphatase activity further validating their pluripotent state. Following this comprehensive characterization, the iPSCs were successfully differentiated into cardiomyocyte-like cells using 5-azacytidine. Our research highlights the innovative application of OCTNPs as a safe and effective alternative to viral vectors, addressing key limitations of iPSC reprogramming. The novel application of OCTNPs for efficient gene delivery demonstrates a powerful tool for advancing stem cell technologies, minimizing risks associated with viral vectors. These findings pave the way for further innovations in biotechnological applications, particularly in tissue engineering and personalized medicine.

28 April 2020 in Journal of Microencapsulation
Verified
Journal Article
Closed access
HVHanife Sevgi Varlı
Hanife Sevgi Varlı
FAFunda Alkan
Funda Alkan
FKFatma Ceren Kırmızıtaş
Fatma Ceren Kırmızıtaş
MDMurat Demirbilek
Murat Demirbilek
NTNelisa TÜRKOĞLU
Nelisa TÜRKOĞLU
Aim: In this study we aimed to develop a polycationic non-viral carrier for the delivery of the reprogramming factors to the L929 fibroblast cell. Methods: We have prepared (3-hydroxybutyrate-co-3-hydroxyhexanoate) PHBHHx based nanoparticles with the solvent diffusion method. Cytotoxicity of PXNs was determined via MTT assay. Transfection efficiency was evaluated via screening GFP expression by fluorescence microscopy. The expression of reprogramming factors (Oct4, Klf4, and Sox2) were determined by RT-qPCR. Results: PXNs with 32.9 ± 0.41mV zeta potential and 177.6 ± 0.80 nm size were used for transfection of L929 Fbroblast cells. The percentage of cell viability of PXN were between 91.8%(±2.9) and 42.1%(±1.3). The transfection efficiency was found as 71,6%(±3,5). According to RT-qPCR data the rate of transfection factors were significantly increased after the 11th cycle compared to non-transfected cells. Based on these results, it can be concluded that newly developed PXN is thought to be an effective tool for reprogramming cells.

21 August 2025 in Trends in Pharmacy
Verified
Journal Article
Open access
PDF file
HVHanife Sevgi Varlı
Hanife Sevgi Varlı
Background: Nanoparticles have gained significant attention in biomedical applications, particularly in gene delivery, due to their tunable physicochemical properties. A new core nanoparticle, O-CaP-2 (Octadecylamine- Calcium Phosphate core nanoparticle), was synthesized and evaluated for its physicochemical properties, cytocompatibility, and gene transfer efficiency. Methods: In this study, 2 different nanoparticles were synthesized and characterized, and their transfection efficiency was evaluated. A core-shell structure was formed by coating calcium phosphate nanoparticles (CaP NPs) with octadecylamine nanoparticles (OD NPs) to enhance stability and cellular uptake. The synthesized nanoparticles were characterized in terms of size and surface charge usinga Zetasizer. Morphological properties were analyzed by scanning electron microscopy (SEM), while chemical interactions were investigated through Fourier transform infrared spectroscopy (FTIR). The cytotoxicity of the nanoparticles was assessedusing MTT (2,5-diphenyltetrazolium bromide [MTT, Thiazolyl blue]) assay over a 24-hour period. Finally, nanoparticles exhibiting optimal physicochemical properties and biocompatibility were selected for transfection studies. The transfection efficiency of these nanoparticles was evaluated to determine their potential for gene delivery applications. Results: The O-CaP-2 nanoparticle, with a zeta potential of +24.3 mV, an average size of 184 nm, and a PDI (polydispersity index) of 0.2, was selected for further evaluation. Scanning electron microscopy imaging showed dense, spherical particles, while FTIR analysis confirmed the presence of octadecylamine and calcium phosphate. MTT assays indicated no cytotoxic effects across tested concentrations. Gene transfer studies achieved a transfection efficiency of 78% ± 5.18%, demonstrating O-CaP2’s potential as a safe and effective gene delivery vector. Conclusion: The O-CaP-2 core nanoparticle, characterized by its favorable physicochemical properties, biocompatibility, and high transfection efficiency, demonstrates strong potential as a safe and effective non-viral gene delivery vector.Cite this article as: Varlı, H. S. Development and evaluation of O-CaP core nanoparticles for efficient non-viral gene delivery. Trends Pharm, 2025, 2, 0006. doi: 10.5152/TrendsPharm.2025.25006.